Benign Breast Disease and the Risk of Breast Cancer

Autor: Vera J. Suman, Karthik Ghosh, Cassann Blake, Celine M. Vachon, Daniel W. Visscher, Lynn C. Hartmann, Thea D. Tlsty, V. Shane Pankratz, Robert A. Vierkant, Wilma L. Lingle, Amy C. Degnim, L. Joseph Melton, Jo Johnson, David W. Hillman, Thomas A. Sellers, Shaun D. Maloney, Marlene H. Frost
Rok vydání: 2016
Předmět:
CA15-3
Oncology
Medical and Health Sciences
Atypical hyperplasia
Cohort Studies
Breast Diseases
0302 clinical medicine
Atypia
Breast
Family history
Age of Onset
skin and connective tissue diseases
Fibrocystic Breast Disease
Cancer
Obstetrics
Obstetrics and Gynecology
General Medicine
Middle Aged
Risk factors for breast cancer
030220 oncology & carcinogenesis
Female
Patient Safety
Breast disease
Risk
Adult
medicine.medical_specialty
Breast Neoplasms
030209 endocrinology & metabolism
Paediatrics and Reproductive Medicine
03 medical and health sciences
Breast cancer
Clinical Research
General & Internal Medicine
Internal medicine
Breast Cancer
medicine
Humans
Risk factor
Obstetrics & Reproductive Medicine
Proportional Hazards Models
Aged
Gynecology
Hyperplasia
business.industry
Prevention
medicine.disease
Relative risk
business
Zdroj: The New England journal of medicine, vol 353, iss 3
Obstetrical & Gynecological Survey, vol 71, iss 8
Obstetrical and Gynecological Survey, vol 71, iss 8
ISSN: 0029-7828
DOI: 10.1097/01.ogx.0000489578.68399.d7
Popis: BACKGROUND Benign breast disease is an important risk factor for breast cancer. We studied a large group of women with benign breast disease to obtain reliable estimates of this risk. METHODS We identified all women who received a diagnosis of benign breast disease at the Mayo Clinic between 1967 and 1991. Breast-cancer events were obtained from medical records and questionnaires. To estimate relative risks, we compared the number of observed breast cancers with the number expected on the basis of the rates of breast cancer in the Iowa Surveillance, Epidemiology, and End Results registry. RESULTS We followed 9087 women for a median of 15 years. The histologic findings were nonproliferative lesions in 67 percent of women, proliferative lesions without atypia in 30 percent, and atypical hyperplasia in 4 percent. To date, 707 breast cancers have developed. The relative risk of breast cancer for the cohort was 1.56 (95 percent confidence interval, 1.45 to 1.68), and this increased risk persisted for at least 25 years after biopsy. The relative risk associated with atypia was 4.24 (95 percent confidence interval, 3.26 to 5.41), as compared with a relative risk of 1.88 (95 percent confidence interval, 1.66 to 2.12) for proliferative changes without atypia and of 1.27 (95 percent confidence interval, 1.15 to 1.41) for nonproliferative lesions. The strength of the family history of breast cancer, available for 4808 women, was a risk factor that was independent of histologic findings. No increased risk was found among women with no family history and nonproliferative findings. In the first 10 years after the initial biopsy, an excess of cancers occurred in the same breast, especially in women with atypia. CONCLUSIONS Risk factors for breast cancer after the diagnosis of benign breast disease include the histologic classification of a benign breast lesion and a family history of breast cancer.
Databáze: OpenAIRE